Castle Biosciences, Inc. (CSTL) vs Vor Biopharma Inc. (VOR)

A side-by-side comparison of Castle Biosciences, Inc. and Vor Biopharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CSTL vs VOR

growth of $100 · dividends reinvested · last 6y
CSTL -58.4% (-13.6%/yr)VOR -97.5% (-46.0%/yr)CSTL compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020222023202420252026$42$2
CSTL VOR

CSTL vs VOR: by the numbers

  • •CSTL is the larger company ($1.02B vs $998M market cap).
  • •Both run net losses; VOR's is the smaller (0.00% vs -5.43% net margin).

Metrics side by side

Valuation

MetricCSTLVOR
P/S ratio2.86N/A
P/B ratio2.18N/A

Profitability

MetricCSTLVOR
Gross margin77.26%0.00%
Operating margin-8.99%0.00%
Net margin-5.43%0.00%
ROE-4.13%N/A
ROIC-6.33%-32.24%

Growth (annualized)

MetricCSTLVOR
Revenue CAGR (5Y)35.55%N/A
Total return CAGR (5Y)-10.28%-42.54%

Frequently asked

How have CSTL and VOR total returns compared?
Over the past 5 years, CSTL delivered -10.28% and VOR delivered -42.54% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.